Hot Pursuit     30-Jun-23
Zydus Lifesciences Ltd soars 0.09%, rises for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 583, up 0.09% on the day as on 12:44 IST on the NSE. The stock is up 61.36% in last one year as compared to a 21.45% gain in NIFTY and a 12.38% gain in the Nifty Metal.

Zydus Lifesciences Ltd gained for a fifth straight session today. The stock is quoting at Rs 583, up 0.09% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.84% on the day, quoting at 19130.9. The Sensex is at 64495.2, up 0.91%. Zydus Lifesciences Ltd has added around 16.07% in last one month.

Meanwhile, Nifty Metal index of which Zydus Lifesciences Ltd is a constituent, has added around 8.68% in last one month and is currently quoting at 13622.75, up 1.15% on the day. The volume in the stock stood at 8.61 lakh shares today, compared to the daily average of 12.37 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 587.05, up 0.7% on the day. Zydus Lifesciences Ltd is up 61.36% in last one year as compared to a 21.45% gain in NIFTY and a 12.38% gain in the Nifty Metal index.

The PE of the stock is 35.02 based on TTM earnings ending March 23.

Previous News
  Zydus Lifesciences to table results
 ( Corporate News - 21-Jan-25   14:18 )
  Zydus Life gets US FDA nod for UTI treatment drug Methenamine
 ( Hot Pursuit - 12-Mar-25   13:32 )
  Zydus Life inks pact to acquire majority stake in Amplitude Surgical
 ( Hot Pursuit - 11-Mar-25   15:44 )
  Zydus receives USFDA warning for injectables manufacturing unit at Jarod
 ( Corporate News - 30-Aug-24   14:49 )
  Zydus Lifesciences receives USFDA approval for Scopolamine Transdermal System
 ( Corporate News - 30-Aug-24   15:12 )
  Zydus Lifesciences consolidated net profit rises 298.62% in the March 2024 quarter
 ( Results - Announcements 17-May-24   16:25 )
  Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets
 ( Corporate News - 12-Mar-25   12:59 )
  Zydus completes acquisition of 50% stake in Sterling Biotech
 ( Corporate News - 30-Aug-24   11:21 )
  Zydus' transdermal manufacturing site completes USFDA inspection
 ( Corporate News - 19-Jul-24   19:26 )
  Zydus acquires 50% stake in Sterling Biotech
 ( Corporate News - 24-Aug-24   11:33 )
  Sensex up 203 pts, oil & gas shares advance
 ( Market Commentary - Mid-Session 24-Apr-24   14:36 )
Other Stories
  GPT Infra commissions steel girder manufacturing facility in West Bengal
  24-Apr-25   12:41
  Axiscades Tech rallies as subsidiary appoints Anurag Sharma as CEO
  24-Apr-25   12:36
  Eldeco Housing & Industries Ltd leads gainers in 'B' group
  24-Apr-25   12:15
  Max Estates rises after taking over Noida-based 'Delhi One' project
  24-Apr-25   12:10
  Vascon Engineers spurts on securing Rs 85-cr LoI
  24-Apr-25   12:02
  KIOCL Ltd leads gainers in 'A' group
  24-Apr-25   12:00
  Den Networks Q4 PAT fall 21% YoY to Rs 62 cr
  24-Apr-25   11:51
  Bajaj Housing Finance gains as Q4 PAT rallies 54% YoY to Rs 587 crore
  24-Apr-25   11:48
  Lupin rallies after receiving USFDA nod for Tolvaptan tablets
  24-Apr-25   11:40
  Tamilnad Mercantile Bank spurts after good Q4 outcome
  24-Apr-25   11:26
Back Top